SVRA
Savara Inc.
There isn't enough reported data to score SVRA yet.
SVRA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
SVRA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
SVRA PE Valuation
SVRA has no meaningful PE right now: it lost money over the past year.
SVRA Forward outlook
There aren't enough analyst estimates for SVRA to show an outlook.
SVRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.61 | -$0.07 |
| Q2 2026 | -$0.58 | -$0.07 |
| Q1 2026 | -$0.56 | -$0.07 |
| Q4 2025 | -$0.53 | -$0.05 |
| Q3 2025 | -$0.54 | -$0.11 |
| Q2 2025 | -$0.51 | -$0.09 |
| Q1 2025 | -$0.49 | -$0.12 |
| Q4 2024 | -$0.48 | -$0.15 |
SVRA is still losing money, but far less than before: $0.61 per share over the past year, against $1.93 at its worst in late 2019.
SVRA Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2020 | -1301200% | N/A |
| Q3 2020 | -4213% | N/A |
SVRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$42.8M | -$20.3M |
| Q2 2026 | -$30M | -$3.7M |
| Q1 2026 | -$33.1M | -$5.9M |
| Q4 2025 | -$25.1M | -$1.8M |
| Q3 2025 | -$22.5M | +$139K |
| Q2 2025 | -$26.3M | -$3.8M |
| Q1 2025 | -$27.2M | -$6.5M |
| Q4 2024 | -$23.3M | -$7.6M |
SVRA has burned cash in almost every quarter: −$131M over the past year, against −$99M the year before.
SVRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +650K shares |
| 1 year | +17% | +37.8M shares |
| 3 years | +55% | +89.9M shares |
| 5 years | +67% | +102M shares |
| Available history | +343% | +197M shares |
SVRA has 254M diluted shares, up 17% from a year ago.
SVRA Net Leverage
SVRA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SVRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.0 | Neutral |
| Stochastic | 35.5 | Neutral |
SVRA's weekly RSI is 44 (neutral) and its Stochastic is 36 (neutral).
SVRA PE vs Healthcare Sector
SVRA has no meaningful PE right now: it lost money over the past year.
SVRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.72 | 0% above |
| 20 week MA | $5.23 | 9.8% below |
| 50 week MA | $5.44 | 13% below |
| 100 week MA | $4.26 | 11% above |
| 200 week MA | $3.98 | 19% above |
SVRA has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 19% above its 200-week average.
SVRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.73 | $1.31 | -24% |
| 2021 | $1.31 | $1.29 | -1.5% |
| 2022 | $1.29 | $1.50 | +16% |
| 2023 | $1.50 | $4.70 | +213% |
| 2024 | $4.70 | $3.15 | -33% |
| 2025 | $3.15 | $6.45 | +105% |
| 2026 YTD | $6.45 | $4.72 | -27% |
SVRA has finished lower in three of the last six years. It's down 27% so far in 2026.